We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Product News

Medivation and Astellas Announce Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients

MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen progression and radiographic progression.
Product News

Marina Biotech Publishes Pre-Clinical Research on RNAi-Based Therapeutics Targeting Survivin and PLK1 in Bladder Cancer

Research published in molecular therapy shows gene specific silencing resulted in up to a 60-fold decrease in tumor volume.
Product News

Precision Therapeutics and Med BioGene Partner to Commercialize LungExpress Dx™

LungExpress Dx™ is a proprietary gene expression-based test to improve upon staging for identifying those patients with early-stage NSCLC.
Product News

Celsion Announces ThermoDox® Preclinical Data Publication and Presentations at Upcoming Scientific Conferences

Data support clinical studies in bone cancer planned for 2011.
Product News

Poniard Pharmaceuticals Receives Chinese State FDA Approval for Clinical Development of Picoplatin

Company receives CTA approval to conduct two Phase III clinical studies of picoplatin, in the treatment of second-line SCLC and second-line ovarian cancer in the People's Republic of China.
Product News

Cellceutix Makes Breakthrough in Cancer Research by Activating p53, the "Guardian Angel of the Human Genome"

p53 is a tumor suppressor protein that is encoded by the TP53 gene in humans and has been widely regarded as possibly holding a key to the future of cancer therapies.
Product News

Helix BioPharma Reports Issuance of U.S. Patent for the Lung Cancer-Specific Antibody Used in Its Drug Candidate L-DOS47

L-DOS47 combines Helix's DOS47 technology with NRC's highly specialized camelid-derived single domain antibody to identify a unique CEACAM6 antigenic site associated with NSCLC cells.
Product News

DiaMedica Announces Positive Results from a Hypertension Study With its GSK3B-Blocking Antibody

DiaMedica announces antihypertensive results with antibody DM-204.
Product News

Helix BioPharma Files European Clinical Trial Application for a Phase I/II Study of its Lung Cancer Drug Candidate L-DOS47

L-DOS47 is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic, non-small cell lung cancer.
Product News

Immunotope and Immunovaccine Announce U.S. Patent for Therapeutic Cancer Vaccine Antigens

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.
Advertisement